Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

1.

Role of cytokines and chemokines in idiopathic inflammatory myopathies.

De Paepe B, Creus KK, De Bleecker JL.

Curr Opin Rheumatol. 2009 Nov;21(6):610-6. doi: 10.1097/BOR.0b013e3283317b31. Review.

PMID:
19726994
2.

Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies.

de Padilla CM, Reed AM.

Curr Opin Rheumatol. 2008 Nov;20(6):669-74. doi: 10.1097/BOR.0b013e3283157538. Review.

PMID:
18946326
3.

Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.

De Paepe B, De Keyzer K, Martin JJ, De Bleecker JL.

Acta Neuropathol. 2005 Jun;109(6):576-82. Epub 2005 Jun 4.

PMID:
15937690
4.

New developments in the role of cytokines and chemokines in inflammatory myopathies.

Lundberg IE, Nyberg P.

Curr Opin Rheumatol. 1998 Nov;10(6):521-9. Review.

PMID:
9812212
5.

Chemokine profile of different inflammatory myopathies reflects humoral versus cytotoxic immune responses.

De Paepe B, Creus KK, De Bleecker JL.

Ann N Y Acad Sci. 2007 Aug;1109:441-53.

PMID:
17785333
6.

Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies.

Lundberg I, Ulfgren AK, Nyberg P, Andersson U, Klareskog L.

Arthritis Rheum. 1997 May;40(5):865-74.

PMID:
9153548
7.

Local expression of cytokines in idiopathic inflammatory myopathies.

Lepidi H, Frances V, Figarella-Branger D, Bartoli C, Machado-Baeta A, Pellissier JF.

Neuropathol Appl Neurobiol. 1998 Feb;24(1):73-9.

PMID:
9549732
8.
9.

Differential expression of chemokines in inflammatory myopathies.

De Bleecker JL, De Paepe B, Vanwalleghem IE, Schröder JM.

Neurology. 2002 Jun 25;58(12):1779-85.

PMID:
12084877
10.

Novel aspects on the contribution of T cells and dendritic cells in the pathogenesis of myositis.

Chevrel G, Page G, Miossec P.

Autoimmunity. 2006 May;39(3):171-6. Review.

PMID:
16769650
11.

Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies.

Wiendl H, Mitsdoerffer M, Schneider D, Melms A, Lochmuller H, Hohlfeld R, Weller M.

Brain. 2003 May;126(Pt 5):1026-35.

PMID:
12690043
12.

Animal models in myositis.

Katsumata Y, Ascherman DP.

Curr Opin Rheumatol. 2008 Nov;20(6):681-5. doi: 10.1097/BOR.0b013e328310e0ac. Review.

PMID:
18946328
13.

The predominance of beta (CC) chemokine transcripts in idiopathic inflammatory muscle diseases.

Adams EM, Kirkley J, Eidelman G, Dohlman J, Plotz PH.

Proc Assoc Am Physicians. 1997 May;109(3):275-85.

PMID:
9154644
14.
15.

Cytokines in idiopathic inflammatory myopathies.

Salomonsson S, Lundberg IE.

Autoimmunity. 2006 May;39(3):177-90. Review.

PMID:
16769651
16.

Chemokines in idiopathic inflammatory myopathies.

De Paepe B, Creus KK, De Bleecker JL.

Front Biosci. 2008 Jan 1;13:2548-77. Review.

PMID:
17981734
17.

[Myositides].

Bornemann A, Heitmann S, Lindner A.

Pathologe. 2009 Sep;30(5):352-6. doi: 10.1007/s00292-009-1167-7. Review. German.

PMID:
19618187
19.

Molecular immunology and genetics of inflammatory muscle diseases.

Dalakas MC.

Arch Neurol. 1998 Dec;55(12):1509-12. Review.

PMID:
9865793

Supplemental Content

Support Center